论文部分内容阅读
目的观察厄贝沙坦治疗高血压伴阵发性房颤的临床效果。方法 78例高血压病合并房颤患者随机分为对照组和观察组,对照组给予胺碘酮治疗,观察组给予厄贝沙坦治疗。结果观察组和对照组治疗后较治疗前血压均明显下降(P<0.05),观察组房颤发生率、房颤发作频率、房颤持续时间均低于对照组(P<0.05)。结论厄贝沙坦具有一定的抗心律失常作用,对高血压病合并房颤者有较好的疗效。
Objective To observe the clinical effect of irbesartan on hypertension with paroxysmal atrial fibrillation. Methods 78 patients with hypertension and atrial fibrillation were randomly divided into control group and observation group. The control group was treated with amiodarone. The observation group was treated with irbesartan. Results Compared with the control group, the observation group and the control group had significantly lower blood pressure before treatment (P <0.05). The incidence of atrial fibrillation, the frequency of atrial fibrillation and the duration of atrial fibrillation in the observation group were lower than those in the control group (P <0.05). Conclusion Irbesartan has a certain anti-arrhythmic effect on hypertension with atrial fibrillation have a good effect.